Efficacy of lanreotide 30 mg on prevention of pain relapse after oral refeeding in patients with necrotizing acute pancreatitis. A phase II prospective multicentre study.
Efficacy of lanreotide 30 mg on prevention of pain relapse after oral refeeding in patients with acute necrotizing pancreatitis, a prospective multicentre study phase II.